| 发明名称 |
STEM CELLS FOR ANTI-ANGIOGENIC THERAPY IN AGE-RELATED MACULAR DEGENERATION, DIABETIC RETINOPATHY, CORNEAL VASCULARISATION AND CANCER |
| 摘要 |
The present invention relates to production of a stem cell expressing an anti-angiogenic protein. The stem cells are used to inhibit angiogenesis for treatment of macular degeneration, corneal vascularisation, cancer and diabetic retinopathy. |
| 申请公布号 |
US2017020958(A1) |
申请公布日期 |
2017.01.26 |
| 申请号 |
US201615098185 |
申请日期 |
2016.04.13 |
| 申请人 |
CRYOCORD SDN. BHD. |
发明人 |
YONG Then Khong |
| 分类号 |
A61K38/17;C12N5/0775;A61K38/45;A61K35/28;C12N9/12 |
主分类号 |
A61K38/17 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. Genetically-engineered mesenchymal stem cells (MSCs) having a recombinant vector carrying a vascular endothelial growth factor receptor (VEGFR) gene and expressing a vascular endothelial growth factor receptor (VEGFR) polypeptide, wherein the said stem cells inhibit angiogenesis in human body. |
| 地址 |
Cyberjaya MY |
